title: Cost-effectiveness of Statin Therapy for ASCVD--Reply.
authors.affiliation: Department of Health Policy and Management, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.
authors.forename: Ankur
authors.initials: A
authors.lastname: Pandya
authors.affiliation: Department of Health Policy and Management, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.
authors.forename: Milton C
authors.initials: MC
authors.lastname: Weinstein
authors.affiliation: Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
authors.forename: Thomas A
authors.initials: TA
authors.lastname: Gaziano
mesh_terms: D050197:Atherosclerosis / Q000188:drug therapy*; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000191:economics* / Q000627:therapeutic use*; D008297:Male; D019057:Quality-Adjusted Life Years
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors